I ask unanimous consent that the Committee on Commerce, Science, and Transportation be authorized to meet during the session of the Senate on April 17, 2013, at 2:30 p.m. in room 253 of the Russell Senate Office Building. The Committee…
Bob Menendez
The Public Record
Robert Menendez is a prominent Democratic politician currently serving as a member of the United States Senate, representing New Jersey. He was first elected to the Senate in 2006 and has since been re-elected multiple times. Menendez has played a significant role in various policy areas, including foreign relations, immigration reform, and healthcare. He has served on several Senate committees, including the Senate Foreign Relations Committee, where he has been an advocate for human rights and democracy abroad.
I rise as a parent, as a father, as an American who saw the horror of Newtown. Too many times I have come to this Senate floor to say I offer my thoughts and prayers to the parents of the victims of an assault weapon attack. Too many…
I ask unanimous consent that the Committee on Homeland Security and Governmental Affairs be authorized to meet during the session of the Senate on April 17, 2013, at 10 a.m. The PRESIDING OFFICER. Without objection, it is so ordered…
I ask unanimous consent that the Committee on Finance be authorized to meet during the session of the Senate on April 17, 2013, at 10 a.m., in room 215 of the Dirksen Senate Office Building, to conduct a hearing entitled ``The President's…
I have long held that real long-term savings can and should be found by encouraging the efficient delivery of health care.
cutting in this particular field, while I understand the challenges and the trade-offs, is just undermining the very essence of some of the goals that we intended under the Affordable Care Act.
Is it not further true that under the Affordable Care Act, that with the donut-hole rebates and other cost-containment provisions, that beneficiaries have not only saved about $6 billion in drug costs since the law was signed, but that…
So how do we ensure that the research and development that makes us the leader in the world and that makes us globally competitive, and, maybe even more important than that, creates life-saving, life-enhancing drugs, does not get…
I think that is where some of the structural reforms can and should be made.
I am a little dismayed at some of the so-called savings that are identified in the Medicare program.
At the end of the day, those who were harmed should have the appropriate relief.





